Fairmount Funds Management LLC 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 3:45 pm Purchase | 2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 5,869,037 9.900% | 992 (+0.02%) | Filing |
| 2024-11-14 4:15 pm Purchase | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 5,868,045 9.900% | 2,234,080 (+61.48%) | Filing |
| 2024-02-14 3:48 pm Purchase | 2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 3,633,965 9.900% | 1,732,568 (+91.12%) | Filing |
| 2023-02-14 3:45 pm Purchase | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 1,901,397 6.900% | 989,661 (+108.55%) | Filing |
| 2022-02-08 4:31 pm Sale | 2021-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 911,736 7.000% | -62,869 (-6.45%) | Filing |
| 2021-09-22 3:57 pm Purchase | 2021-09-20 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 974,605 7.600% | 974,605 (New Position) | Filing |